Avexis, INC
clinical-stage gene therapy
Based in IL
🤖
AI Overview
With $218K in lobbying spend across 12 quarterly filings, Avexis, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2020.
$218K
Total Spend
3
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $144K |
| 2019 | $36K |
| 2020 | $38K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Avexis, INC disclosed contacting in their lobbying filings.
HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
​clinical-stage gene therapy
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Health Care Service Corporation, a Mutual Legal Reserve Company (Hcsc)
$52.8M total spend
Advocate Aurora Health, INC.
$16.8M total spend
American Association of Orthopaedic Surgeons
$14.7M total spend
Illinois Health & Hospital Association (Formerly Illinois Hospital Association)
$4.9M total spend
Muscular Dystrophy Association, INC.
$3.5M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.